Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

An engineered substance P variant for receptor-mediated delivery of synthetic antibodies into tumor cells.

An engineered substance P variant for receptor-mediated delivery of synthetic antibodies into tumor cells. Proc Natl Acad Sci U S A. 2009 Jul 07; 106(27):11011-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.